Medacta Group Stock

Medacta Group Stocks 2024

Medacta Group Stocks

19.99 M

Ticker

MOVE.SW

ISIN

CH0468525222

WKN

A2PFTD

In 2024, Medacta Group had 19.99 M outstanding stocks, a 0% change from the 19.99 M stocks in the previous year.

The Medacta Group Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2029e19.99
2028e19.99
2027e19.99
2026e19.99
2025e19.99
2024e19.99
202319.99
202220
202120
202020
201920
201820
201720
201620

Medacta Group shares outstanding

The number of shares was Medacta Group in 2023 — This indicates how many shares 19.992 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Medacta Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medacta Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medacta Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medacta Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medacta Group Aktienanalyse

What does Medacta Group do?

The Medacta Group SA is a leading global company in the development, manufacturing, and marketing of medical devices and implants for the orthopedic industry. The company was founded in 1999 by Swiss entrepreneur Alberto Siccardi and is headquartered in Switzerland. The Medacta Group SA has its origins in one person - Alberto Siccardi. As a former athlete and successful entrepreneur, he had a vision that he put into action. He founded the Medacta Group and began focusing on the development and manufacturing of innovative orthopedic devices and implants. The Medacta Group has an innovative business model because the company is able to handle everything from research and development to marketing and sales of its products. This means that Medacta combines all steps from idea to end product under one roof and has complete control over the entire process. The Medacta Group SA is divided into three business areas: orthopedics, spine, and sports medicine. In the orthopedic field, the company manufactures hip and knee joint implants, as well as shoulder and elbow implants. Medacta also offers technologies that help extend the lifespan of artificial joints. In the spine field, the company provides instruments and implants for spine surgery. Medacta has a high level of expertise in this field and is known for innovative products that contribute to improving patient treatment. In the sports medicine field, the Medacta Group offers solutions for sports injuries. The company has developed a wide range of technologies and products that accelerate the healing process and support rehabilitation. Some of Medacta's most well-known products are the AMIS (Anterior Minimally Invasive Surgery) hip joint system and the GMK (General Medacta Knee) knee joint system. The AMIS system is a minimally invasive procedure for hip joint surgery that aims to shorten rehabilitation time and reduce the risk of complications. The GMK system is an innovative knee joint system that allows natural joint mechanics and approximates the natural knee pivot point. Medacta has also developed a range of software solutions that support surgeons in the planning and execution of operations. These solutions provide detailed visualizations and allow for precise planning of procedures. In conclusion, the Medacta Group SA is a global leader in the development and manufacturing of medical devices and implants for orthopedics, spine, and sports medicine. The company has an innovative business model that allows for complete control of the entire manufacturing process. Through the development of innovative products and technologies, the Medacta Group supports the treatment and rehabilitation of patients worldwide. Medacta Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Medacta Group's Shares Outstanding

Medacta Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Medacta Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Medacta Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Medacta Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Medacta Group stock

How many stocks are there of Medacta Group?

The current number of stocks of Medacta Group is 19.99 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Medacta Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Medacta Group evolved in recent years?

The number of shares of Medacta Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Medacta Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Medacta Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Medacta Group pay?

Over the past 12 months, Medacta Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medacta Group is expected to pay a dividend of 0.31 EUR.

What is the dividend yield of Medacta Group?

The current dividend yield of Medacta Group is .

When does Medacta Group pay dividends?

Medacta Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medacta Group?

Medacta Group paid dividends every year for the past 0 years.

What is the dividend of Medacta Group?

For the upcoming 12 months, dividends amounting to 0.31 EUR are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Medacta Group located?

Medacta Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medacta Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medacta Group from 5/14/2024 amounting to 0.275 EUR, you needed to have the stock in your portfolio before the ex-date on 5/10/2024.

When did Medacta Group pay the last dividend?

The last dividend was paid out on 5/14/2024.

What was the dividend of Medacta Group in the year 2023?

In the year 2023, Medacta Group distributed 0.268 EUR as dividends.

In which currency does Medacta Group pay out the dividend?

The dividends of Medacta Group are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medacta Group

Our stock analysis for Medacta Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medacta Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.